{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:44:08Z","timestamp":1792467848740,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1I1A3074384"],"award-info":[{"award-number":["NRF-2020R1I1A3074384"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A5A2017323"],"award-info":[{"award-number":["NRF-2020R1A5A2017323"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12272-025-01554-0","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:18:56Z","timestamp":1752851936000},"page":"798-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sphingolipid modulation and anti-tumor activity of Jaspine B in HepG2 bearing mice"],"prefix":"10.1007","volume":"48","author":[{"given":"Jihoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyeon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyeong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Koo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4564-709X","authenticated-orcid":false,"given":"Im-Sook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-18-3803","volume":"79","author":"S Acharya","year":"2019","unstructured":"Acharya S, Yao J, Li P, Zhang C, Lowery FJ, Zhang Q, Guo H, Qu J, Yang F, Wistuba II, Piwnica-Worms H, Sahin AA, Yu D (2019) Sphingosine kinase 1 signaling promotes metastasis of triple-negative breast cancer. Cancer Res 79:4211\u20134226. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3803","journal-title":"Cancer Res"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/B978-0-12-394274-6.00006-6","volume":"117","author":"H Alshaker","year":"2013","unstructured":"Alshaker H, Sauer L, Monteil D, Ottaviani S, Srivats S, B\u00f6hler T, Pchejetski D (2013) Therapeutic potential of targeting SK1 in human cancers. Adv Cancer Res 117:143\u2013200. https:\/\/doi.org\/10.1016\/B978-0-12-394274-6.00006-6","journal-title":"Adv Cancer Res"},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/sj.onc.1208019","volume":"24","author":"M Bektas","year":"2005","unstructured":"Bektas M, Jolly PS, Muller C, Eberle J, Spiegel S, Geilen CC (2005) Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24:178\u2013187. https:\/\/doi.org\/10.1038\/sj.onc.1208019","journal-title":"Oncogene"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.3390\/ijms23137257","volume":"23","author":"N Bielsa","year":"2022","unstructured":"Bielsa N, Casasampere M, Abad JL, Enrich C, Delgado A, Fabri\u00e0s G, Lizcano JM, Casas J (2022) Methuosis contributes to Jaspine-B-induced cell death. Int J Mol Sci 23:7257. https:\/\/doi.org\/10.3390\/ijms23137257","journal-title":"Int J Mol Sci"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.21873\/anticanres","volume":"41","author":"A Bogdanova","year":"2021","unstructured":"Bogdanova A, Kello M, Macejova A, Nosalova N, Petik P, Takac P, Martinkova M, Mezeiova E, Mirossay L, Gal P, Pilatova MB (2021) Jaspine B hydrochloride-induced apoptosis in HeLa cells is associated with disrupted sphingolipid metabolism and ceramide overload. Anticancer Res 41:2875\u20132883. https:\/\/doi.org\/10.21873\/anticanres","journal-title":"Anticancer Res"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3892\/ol.2017.5732","volume":"13","author":"H Cai","year":"2017","unstructured":"Cai H, Xie X, Ji L, Ruan X, Zheng Z (2017) Sphingosine kinase 1: a novel independent prognosis biomarker in hepatocellular carcinoma. Oncol Lett 13:2316\u20132322. https:\/\/doi.org\/10.3892\/ol.2017.5732","journal-title":"Oncol Lett"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bmc.2008.11.026","volume":"17","author":"D Canals","year":"2009","unstructured":"Canals D, Mormeneo D, Fabri\u00e0s G, Llebaria A, Casas J, Delgado A (2009) Synthesis and biological properties of Pachastrissamine (Jaspine B) and diastereoisomeric jaspines. Bioorg Med Chem 17:235\u2013241. https:\/\/doi.org\/10.1016\/j.bmc.2008.11.026","journal-title":"Bioorg Med Chem"},{"key":"1554_CR8","doi-asserted-by":"publisher","first-page":"15635","DOI":"10.18632\/oncotarget.24583","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Qi Y, Zhao Y, Kaczorowski D, Couttas TA, Coleman PR, Don AS, Bertolino P, Gamble JR, Vadas MA, Xia P, McCaughan GW (2018) Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice. Oncotarget 9:15635\u201315649. https:\/\/doi.org\/10.18632\/oncotarget.24583","journal-title":"Oncotarget"},{"key":"1554_CR9","doi-asserted-by":"publisher","first-page":"127754","DOI":"10.1016\/j.bmcl.2020.127754","volume":"34","author":"HJ Chen","year":"2021","unstructured":"Chen HJ, Yang HR, Zhi Y, Yao QQ, Liu B (2021) Evaluation of pyrrolidine-based analog of Jaspine B as potential SphK1 inhibitors against rheumatoid arthritis. Bioorg Med Chem Lett 34:127754. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127754","journal-title":"Bioorg Med Chem Lett"},{"key":"1554_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40005-020-00475-y","volume":"50","author":"MK Choi","year":"2020","unstructured":"Choi MK, Song IS (2020) Recent advances in the formulation of sphingolipid anticancer therapeutics. J Pharm Investig 50:295\u2013307. https:\/\/doi.org\/10.1007\/s40005-020-00475-y","journal-title":"J Pharm Investig"},{"key":"1554_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/md15090279","volume":"15","author":"MK Choi","year":"2017","unstructured":"Choi MK, Lee J, Nam SJ, Kang YJ, Han Y, Choi K, Choi YA, Kwon M, Lee D, Song IS (2017) Pharmacokinetics of Jaspine B and enhancement of intestinal absorption of Jaspine B in the presence of bile acid in Rats. Mar Drugs 15:279. https:\/\/doi.org\/10.3390\/md15090279","journal-title":"Mar Drugs"},{"key":"1554_CR12","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41467-023-37316-z","volume":"14","author":"BJ Choi","year":"2023","unstructured":"Choi BJ, Park MH, Park KH, Han WH, Yoon HJ, Jung HY, Hong JY, Chowdhury MR, Kim KY, Lee J, Song IS, Pang M, Choi MK, Gulbins E, Reichel M, Kornhuber J, Hong CW, Kim C, Kim SH, Schuchman EH, Jin HK, Bae JS (2023) Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer\u2019s disease. Nat Commun 14:1631. https:\/\/doi.org\/10.1038\/s41467-023-37316-z","journal-title":"Nat Commun"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1194\/jlr.M072611","volume":"58","author":"F Cingolani","year":"2017","unstructured":"Cingolani F, Simbari F, Abad JL, Casasampere M, Fabrias G, Futerman AH, Casas J (2017) Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase. J Lipid Res 58:1500\u20131513. https:\/\/doi.org\/10.1194\/jlr.M072611","journal-title":"J Lipid Res"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1074\/jbc.M116.751602","volume":"292","author":"GM Deevska","year":"2017","unstructured":"Deevska GM, Dotson PP 2nd, Karakashian AA, Isaac G, Wrona M, Kelly SB, Merrill AH Jr, Nikolova-Karakashian MN (2017) Novel lnterconnections in lipid metabolism revealed by overexpression of sphingomyelin synthase-1. J Biol Chem 292:5110\u20135122. https:\/\/doi.org\/10.1074\/jbc.M116.751602","journal-title":"J Biol Chem"},{"key":"1554_CR15","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/cells10061278","volume":"10","author":"G Deevska","year":"2021","unstructured":"Deevska G, Dotson PP 2nd, Mitov M, Butterfield DA, Nikolova-Karakashian M (2021) Onset of senescence and steatosis in hepatocytes as a consequence of a shift in the diacylglycerol\/ceramide balance at the plasma membrane. Cells 10:1278. https:\/\/doi.org\/10.3390\/cells10061278","journal-title":"Cells"},{"key":"1554_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0021-9673(01)01422-4","volume":"949","author":"M Fillet","year":"2002","unstructured":"Fillet M, Van Heugen JC, Servais AC, De Graeve J, Crommen J (2002) Separation, identification and quantitation of ceramides in human cancer cells by liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A 949:225\u2013233. https:\/\/doi.org\/10.1016\/s0021-9673(01)01422-4","journal-title":"J Chromatogr A"},{"key":"1554_CR17","first-page":"5962","volume":"63","author":"KJ French","year":"2003","unstructured":"French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962\u20135969","journal-title":"Cancer Res"},{"key":"1554_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nchembio.392","volume":"6","author":"H Fyrst","year":"2010","unstructured":"Fyrst H, Saba JD (2010) An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 6:489\u2013497. https:\/\/doi.org\/10.1038\/nchembio.392","journal-title":"Nat Chem Biol"},{"key":"1554_CR19","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.15252\/embj.201796697","volume":"36","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM (2017) Molecular definitions of autophagy and related processes. EMBO J 36:1811\u20131836. https:\/\/doi.org\/10.15252\/embj.201796697","journal-title":"EMBO J"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3109\/10409238.2011.597737","volume":"46","author":"CR Gault","year":"2011","unstructured":"Gault CR, Obeid LM (2011) Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. Crit Rev Biochem Mol Biol 46:342\u2013351. https:\/\/doi.org\/10.3109\/10409238.2011.597737","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/1535-7163.MCT-08-1096","volume":"8","author":"J Guillermet-Guibert","year":"2009","unstructured":"Guillermet-Guibert J, Davenne L, Pchejetski D, Saint-Laurent N, Brizuela L, Guilbeau-Frugier C, Delisle MB, Cuvillier O, Susini C, Bousquet C (2009) Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Mol Cancer Ther 8:809\u2013820. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-1096","journal-title":"Mol Cancer Ther"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3390\/ijms18091891","volume":"18","author":"N Haddadi","year":"2017","unstructured":"Haddadi N, Lin Y, Simpson AM, Nassif NT, McGowan EM (2017) \u201cDicing and splicing\u201d sphingosine kinase and relevance to cancer. Int J Mol Sci 18:1891. https:\/\/doi.org\/10.3390\/ijms18091891","journal-title":"Int J Mol Sci"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s1359-6446(03)02713-2","volume":"8","author":"B Haefner","year":"2003","unstructured":"Haefner B (2003) Drugs from the deep: marine natural products as drug candidates. Drug Discov Today 8:536\u2013544. https:\/\/doi.org\/10.1016\/s1359-6446(03)02713-2","journal-title":"Drug Discov Today"},{"key":"1554_CR24","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/1541-7786.MCR-18-0409","volume":"17","author":"PC Hart","year":"2019","unstructured":"Hart PC, Chiyoda T, Liu X, Weigert M, Curtis M, Chiang CY, Loth R, Lastra R, McGregor SM, Locasale JW, Lengyel E, Romero IL (2019) SPHK1 is a novel target of metformin in ovarian cancer. Mol Cancer Res 17:870\u2013881. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0409","journal-title":"Mol Cancer Res"},{"key":"1554_CR25","doi-asserted-by":"publisher","first-page":"8162","DOI":"10.1002\/jcp.27612","volume":"234","author":"L Hasanifard","year":"2019","unstructured":"Hasanifard L, Sheervalilou R, Majidinia M, Yousefi B (2019) New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance. J Cell Physiol 234:8162\u20138181. https:\/\/doi.org\/10.1002\/jcp.27612","journal-title":"J Cell Physiol"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/B978-0-12-394274-6.00007-8","volume":"117","author":"LA Heffernan-Stroud","year":"2013","unstructured":"Heffernan-Stroud LA, Obeid LM (2013) Sphingosine kinase 1 in cancer. Adv Cancer Res 117:201\u2013235. https:\/\/doi.org\/10.1016\/B978-0-12-394274-6.00007-8","journal-title":"Adv Cancer Res"},{"key":"1554_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40005-023-00650-x","volume":"54","author":"SY Jeon","year":"2024","unstructured":"Jeon SY, Park JH, Kwon MJ, Choi MK, Song IS (2024) Effects of red ginseng extract on the pharmacokinetics and disposition of warfarin via intestinal Cyp2c11 modulation in rats. J Pharm Investig 54:85\u201397. https:\/\/doi.org\/10.1007\/s40005-023-00650-x","journal-title":"J Pharm Investig"},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12906-017-1956-0","volume":"17","author":"Q Jiang","year":"2017","unstructured":"Jiang Q, Yang M, Qu Z, Zhou J, Zhang Q (2017) Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells. BMC Complement Altern Med 17:477. https:\/\/doi.org\/10.1186\/s12906-017-1956-0","journal-title":"BMC Complement Altern Med"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1369\/jhc.4A6606.2005","volume":"53","author":"KR Johnson","year":"2005","unstructured":"Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, Harley RA, Obeid LM (2005) Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem 53:1159\u20131166. https:\/\/doi.org\/10.1369\/jhc.4A6606.2005","journal-title":"J Histochem Cytochem"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1096\/fj.08-117572","volume":"23","author":"T Kawamori","year":"2009","unstructured":"Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Bielawski J, Hannun YA, Obeid LM (2009) Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J 23:405\u2013414. https:\/\/doi.org\/10.1096\/fj.08-117572","journal-title":"FASEB J"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/BJ20110817","volume":"440","author":"Y Kharel","year":"2011","unstructured":"Kharel Y, Mathews TP, Gellett AM, Tomsig JL, Kennedy PC, Moyer ML, Macdonald TL, Lynch KR (2011) Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem J 440:345\u2013353. https:\/\/doi.org\/10.1042\/BJ20110817","journal-title":"Biochem J"},{"key":"1554_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5483\/BMBRep.2019.52.3.012","volume":"52","author":"MK Kim","year":"2019","unstructured":"Kim MK, Lee W, Yoon GH, Chang EJ, Choi SC, Kim SW (2019) Links between accelerated replicative cellular senescence and down-regulation of SPHK1 transcription. BMB Rep 52:220\u2013225. https:\/\/doi.org\/10.5483\/BMBRep.2019.52.3.012","journal-title":"BMB Rep"},{"key":"1554_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.20517\/cdr.2018.06","volume":"1","author":"KM Kreitzburg","year":"2018","unstructured":"Kreitzburg KM, van Waardenburg RCAM, Yoon KJ (2018) Sphingolipid metabolism and drug resistance in ovarian cancer. Cancer Drug Resist 1:181\u2013197. https:\/\/doi.org\/10.20517\/cdr.2018.06","journal-title":"Cancer Drug Resist"},{"key":"1554_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel GT, Maceyka M, Milstien S, Spiegel S (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 12:688\u2013702. https:\/\/doi.org\/10.1038\/nrd4099","journal-title":"Nat Rev Drug Discov"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1021\/np010659y","volume":"65","author":"I Kuroda","year":"2002","unstructured":"Kuroda I, Musman M, Ohtani II, Ichiba T, Tanaka J, Gravalos DG, Higa T (2002) Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp. J Nat Prod 65:1505\u20131506. https:\/\/doi.org\/10.1021\/np010659y","journal-title":"J Nat Prod"},{"key":"1554_CR36","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/md13020824","volume":"13","author":"Y Kwon","year":"2015","unstructured":"Kwon Y, Song J, Bae H, Kim WJ, Lee JY, Han GH, Lee SK, Kim S (2015) Synthesis and biological evaluation of carbocyclic analogues of pachastrissamine. Mar Drugs 13:824\u2013837. https:\/\/doi.org\/10.3390\/md13020824","journal-title":"Mar Drugs"},{"key":"1554_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.imbio.2009.05.009","volume":"215","author":"YG Lee","year":"2010","unstructured":"Lee YG, Lee J, Cho JY (2010) Cell-permeable ceramides act as novel regulators of U937 cell-cell adhesion mediated by CD29, CD98, and CD147. Immunobiology 215:294\u2013303. https:\/\/doi.org\/10.1016\/j.imbio.2009.05.009","journal-title":"Immunobiology"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1186\/s12885-016-2730-2","volume":"16","author":"SO Lee","year":"2016","unstructured":"Lee SO, Kim JS, Lee MS, Lee HJ (2016a) Anti-cancer effect of pristimerin by inhibition of HIF-1alpha involves the SPHK-1 pathway in hypoxic prostate cancer cells. BMC Cancer 16:701. https:\/\/doi.org\/10.1186\/s12885-016-2730-2","journal-title":"BMC Cancer"},{"key":"1554_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5352\/JLS.2016.26.12.1392","volume":"26","author":"J Lee","year":"2016","unstructured":"Lee J, Choi K, Kwon M, Lee D, Choi MK, Song IS (2016b) Differential cytotoxic effects of Jaspine B in various cancer cells. J Life Sci 26:101\u2013109. https:\/\/doi.org\/10.5352\/JLS.2016.26.12.1392","journal-title":"J Life Sci"},{"key":"1554_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/1097-0142(20000901)89:5<983::AID-CNCR7>3.0.CO;2-G","volume":"89","author":"HL Lin","year":"2000","unstructured":"Lin HL, Liu TY, Chau GY, Lui WY, Chi CW (2000) Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89:983\u2013994.\u00a0https:\/\/doi.org\/10.1002\/1097-0142(20000901)89:53.0.CO;2-G","journal-title":"Cancer"},{"key":"1554_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12967-023-04830-z","volume":"22","author":"XT Liu","year":"2024","unstructured":"Liu XT, Huang Y, Liu D, Jiang YC, Zhao M, Chung LH, Han XD, Zhao Y, Chen J, Coleman P, Ting KK, Tran C, Su Y, Dennis CV, Bhatnagar A, Liu K, Don AS, Vadas MA, Gorrell MD, Zhang S, Murray M, Kavurma MM, McCaughan GW, Gamble JR, Qi Y (2024) Targeting the SphK1\/S1P\/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis. J Transl Med 22:43. https:\/\/doi.org\/10.1186\/s12967-023-04830-z","journal-title":"J Transl Med"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s1388-1981(02)00341-4","volume":"1585","author":"M Maceyka","year":"2002","unstructured":"Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585:193\u2013201. https:\/\/doi.org\/10.1016\/s1388-1981(02)00341-4","journal-title":"Biochim Biophys Acta"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/164_2019_217","volume":"259","author":"M Maceyka","year":"2020","unstructured":"Maceyka M, Rohrbach T, Milstien S, Spiegel S (2020) Role of sphingosine kinase 1 and sphingosine-1-phosphate axis in hepatocellular carcinoma. Handb Exp Pharmacol 259:3\u201317. https:\/\/doi.org\/10.1007\/164_2019_217","journal-title":"Handb Exp Pharmacol"},{"key":"1554_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cellsig.2017.01.021","volume":"32","author":"A Maiti","year":"2017","unstructured":"Maiti A, Takabe K, Hait NC (2017) Metastatic triple-negative breast cancer is dependent on SphKs\/S1P signaling for growth and survival. Cell Signal 32:85\u201392. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.021","journal-title":"Cell Signal"},{"key":"1554_CR45","doi-asserted-by":"publisher","first-page":"107737","DOI":"10.1016\/j.carres.2019.06.016","volume":"482","author":"M Martinkov\u00e1","year":"2019","unstructured":"Martinkov\u00e1 M, Gonda J (2019) Synthetic analogues of marine cytotoxic Jaspine B and its stereoisomers. Carbohydrate Res 482:107737. https:\/\/doi.org\/10.1016\/j.carres.2019.06.016","journal-title":"Carbohydrate Res"},{"key":"1554_CR46","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.3390\/cancers15102732","volume":"15","author":"S Mebarek","year":"2023","unstructured":"Mebarek S, Skafi N, Brizuela L (2023) Targeting sphingosine 1-phosphate metabolism as a therapeutic avenue for prostate cancer. Cancers 15:2732. https:\/\/doi.org\/10.3390\/cancers15102732","journal-title":"Cancers"},{"key":"1554_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","volume":"13","author":"SA Morad","year":"2013","unstructured":"Morad SA, Cabot MC (2013) Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13:51\u201365. https:\/\/doi.org\/10.1038\/nrc3398","journal-title":"Nat Rev Cancer"},{"key":"1554_CR48","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/ijms25063354","volume":"25","author":"M Nagahashi","year":"2024","unstructured":"Nagahashi M, Miyoshi Y (2024) Targeting sphingosine-1-phosphate signaling in breast cancer. Int J Mol Sci 25:3354. https:\/\/doi.org\/10.3390\/ijms25063354","journal-title":"Int J Mol Sci"},{"key":"1554_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1479-5876-9-157","volume":"9","author":"J Pan","year":"2011","unstructured":"Pan J, Tao YF, Zhou Z, Cao BR, Wu SY, Zhang YL, Hu SY, Zhao WL, Wang J, Lou GL, Li Z, Feng X, Ni J (2011) An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma. J Transl Med 9:157. https:\/\/doi.org\/10.1186\/1479-5876-9-157","journal-title":"J Transl Med"},{"key":"1554_CR50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","volume":"82","author":"H Rosen","year":"2013","unstructured":"Rosen H, Stevens RC, Hanson M, Roberts E, Oldstone MBA (2013) Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu Rev Biochem 82:637\u2013662. https:\/\/doi.org\/10.1146\/annurev-biochem-062411-130916","journal-title":"Annu Rev Biochem"},{"key":"1554_CR67","doi-asserted-by":"publisher","unstructured":"Rozi\u00e9 A, Santos C, Fabing I, Calsou P, Britton S, G\u00e9nisson Y, Ballereau S (2018) Alkyne-Tagged Analogue of Jaspine B: New Tool for Identifying Jaspine B Mode of Action. Chem Bio Chem 19:2438\u20132442. https:\/\/doi.org\/10.1002\/cbic.201800689","DOI":"10.1002\/cbic.201800689"},{"key":"1554_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bcp.2009.05.002","volume":"78","author":"Y Salma","year":"2009","unstructured":"Salma Y, Lafont E, Therville N, Carpentier S, Bonnafe MJ, Levade T, Genisson Y, Andrieu-Abadie N (2009) The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem Pharmacol 78:477\u2013485. https:\/\/doi.org\/10.1016\/j.bcp.2009.05.002","journal-title":"Biochem Pharmacol"},{"key":"1554_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1021\/cb5008426","volume":"10","author":"WL Santos","year":"2015","unstructured":"Santos WL, Lynch KR (2015) Drugging sphingosine kinases. ACS Chem Biol 10:225\u2013233. https:\/\/doi.org\/10.1021\/cb5008426","journal-title":"ACS Chem Biol"},{"key":"1554_CR53","first-page":"4394","volume":"11","author":"V Satyananda","year":"2021","unstructured":"Satyananda V, Oshi M, Tokumaru Y, Maiti A, Hait N, Matsuyama R, Endo I, Takabe K (2021) Sphingosine 1-phosphate (S1P) produced by sphingosine kinase 1 (SphK1) and exported via ABCC1 is related to hepatocellular carcinoma (HCC) progression. Am J Cancer Res 11:4394\u20134407","journal-title":"Am J Cancer Res"},{"key":"1554_CR54","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.yexcr.2008.02.008","volume":"314","author":"D Separovic","year":"2008","unstructured":"Separovic D, Semaan L, Tarca AL, Awad Maitah MY, Hanada K, Bielawski J, Villani M, Luberto C (2008) Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage. Exp Cell Res 314:1860\u20131868. https:\/\/doi.org\/10.1016\/j.yexcr.2008.02.008","journal-title":"Exp Cell Res"},{"key":"1554_CR55","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2174\/138945008785132402","volume":"9","author":"D Shida","year":"2008","unstructured":"Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9:662\u2013673. https:\/\/doi.org\/10.2174\/138945008785132402","journal-title":"Curr Drug Targets"},{"key":"1554_CR56","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/sj.leu.2404386","volume":"20","author":"S Sobue","year":"2006","unstructured":"Sobue S, Iwasaki T, Sugisaki C, Nagata K, Kikuchi R, Murakami M, Takagi A, Kojima T, Banno Y, Akao Y, Nozawa Y, Kannagi R, Suzuki M, Abe A, Naoe T, Murate T (2006) Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 20:2042\u20132046. https:\/\/doi.org\/10.1038\/sj.leu.2404386","journal-title":"Leukemia"},{"key":"1554_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5806\/AST.2021.34.2.37","volume":"34","author":"IS Song","year":"2021","unstructured":"Song IS, Jeon JH, Lee J, Lim DY, Lee CH, Lee D, Choi MK (2021) Development of Jaspine B analysis using LC-MS\/MS and its application: dose-independent pharmacokinetics of Jaspine B in rats. Anal Sci Technol 34:37\u201345.\u00a0https:\/\/doi.org\/10.5806\/AST.2021.34.2.37","journal-title":"Anal Sci Technol"},{"key":"1554_CR58","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1039\/d4an00304g","volume":"149","author":"PM Sundaraswamy","year":"2024","unstructured":"Sundaraswamy PM, Minami Y, Jayaprakash J, Gowda SGB, Takatsu H, Gowda D, Shin HW, Hui SP (2024) A facile method for monitoring sphingomyelin synthase activity in HeLa cells using liquid chromatography\/mass spectrometry. Analyst 149:3293\u20133301. https:\/\/doi.org\/10.1039\/d4an00304g","journal-title":"Analyst"},{"key":"1554_CR59","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1074\/jbc.M702423200","volume":"282","author":"FG Tafesse","year":"2007","unstructured":"Tafesse FG, Huitema K, Hermansson M, van der Poel S, van den Dikkenberg J, Uphoff A, Somerharju P, Holthuis JC (2007) Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells. J Biol Chem 282:17537\u201317547. https:\/\/doi.org\/10.1074\/jbc.M702423200","journal-title":"J Biol Chem"},{"key":"1554_CR60","doi-asserted-by":"publisher","first-page":"112713","DOI":"10.1016\/j.ejmech.2020.112713","volume":"206","author":"VKR Tangadanchu","year":"2020","unstructured":"Tangadanchu VKR, Jiang H, Yu Y, Graham TJA, Liu H, Rogers BE, Gropler R, Perlmutter J, Tu Z (2020) Structure-activity relationship studies and bioactivity evaluation of 1,2,3-triazole containing analogues as a selective sphingosine kinase-2 inhibitors. Eur J Med Chem 206:112713. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112713","journal-title":"Eur J Med Chem"},{"key":"1554_CR61","doi-asserted-by":"publisher","first-page":"e0149462","DOI":"10.1371\/journal.pone.0149462","volume":"11","author":"B Uranbileg","year":"2016","unstructured":"Uranbileg B, Ikeda H, Kurano M, Enooku K, Sato M, Saigusa D, Aoki J, Ishizawa T, Hasegawa K, Kokudo N, Yatomi Y (2016) Increased mRNA levels of sphingosine kinases and S1P lyase and reduced levels of S1P were observed in hepatocellular carcinoma in association with poorer differentiation and earlier recurrence. PLoS ONE 11:e0149462. https:\/\/doi.org\/10.1371\/journal.pone.0149462","journal-title":"PLoS ONE"},{"key":"1554_CR62","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1016\/j.bmcl.2010.06.019","volume":"20","author":"Y Xiang","year":"2010","unstructured":"Xiang Y, Hirth B, Kane JL Jr, Liao J, Noson KD, Yee C, Asmussen G, Fitzgerald M, Klaus C, Booker M (2010) Discovery of novel sphingosine kinase-1 inhibitors. Part 2. Bioorg Med Chem Lett 20:4550\u20134554. https:\/\/doi.org\/10.1016\/j.bmcl.2010.06.019","journal-title":"Bioorg Med Chem Lett"},{"key":"1554_CR63","doi-asserted-by":"publisher","first-page":"103369","DOI":"10.1016\/j.bioorg.2019.103369","volume":"98","author":"H Yang","year":"2019","unstructured":"Yang H, Li Y, Chai H, Yakura T, Liu B, Yao Q (2019) Synthesis and biological evaluation of 2-epi-Jaspine B analogs as selective sphingosine kinase 1 inhibitors. Bioorg Chem 98:103369. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103369","journal-title":"Bioorg Chem"},{"key":"1554_CR64","doi-asserted-by":"publisher","first-page":"114401","DOI":"10.1016\/j.biopha.2023.114401","volume":"163","author":"X Yi","year":"2023","unstructured":"Yi X, Tang X, Li T, Chen L, He H, Wu X, Xiang C, Cao M, Wang Z, Wang Y, Wang Y, Huang X (2023) Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543. Biomed Pharmacother 163:114401. https:\/\/doi.org\/10.1016\/j.biopha.2023.114401","journal-title":"Biomed Pharmacother"},{"key":"1554_CR65","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/ptr.4673","volume":"26","author":"H Yoo","year":"2012","unstructured":"Yoo H, Lee YS, Lee S, Kim S, Kim TY (2012) Pachastrissamine from Pachastrissa sp. inhibits melanoma cell growth by dual inhibition of Cdk2 and ERK-mediated FOXO3 downregulation. Phytother Res 26:1927\u20131933. https:\/\/doi.org\/10.1002\/ptr.4673","journal-title":"Phytother Res"},{"key":"1554_CR66","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1016\/j.bmc.2011.07.061","volume":"19","author":"Y Yoshimitsu","year":"2011","unstructured":"Yoshimitsu Y, Oishi S, Miyagaki J, Inuki S, Ohno H, Fujii N (2011) Pachastrissamine (Jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C. Bioorg Med Chem 19:5402\u20135408. https:\/\/doi.org\/10.1016\/j.bmc.2011.07.061","journal-title":"Bioorg Med Chem"},{"key":"1554_CR68","doi-asserted-by":"publisher","unstructured":"Zhang K, Chen H, Wu G, Chen K, Yang H (2014) High expression of SPHK1 in sacral chordoma and association with patients\u2019 poor prognosis. Med Oncol 31:247. https:\/\/doi.org\/10.1007\/s12032-014-0247-6","DOI":"10.1007\/s12032-014-0247-6"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01554-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-025-01554-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01554-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:30:57Z","timestamp":1757255457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-025-01554-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":68,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1007\/s12272-025-01554-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Im-Sook Song is an Associate Editor of this journal Archives of Pharmacal Research, but this position had no influence on the editorial decision or the peer review process of this manuscript. Other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}